Journal
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
Volume 3, Issue 1, Pages 11-19Publisher
BMC
DOI: 10.1081/JCMR-100000142
Keywords
accuracy; aortic regurgitation; flow quantification; magnetic resonance; magnetic resonance phase velocity mapping; precision
Funding
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058147] Funding Source: NIH RePORTER
- NHLBI NIH HHS [R01 HL58147] Funding Source: Medline
Ask authors/readers for more resources
Evaluating the in vivo accuracy of magnetic resonance phase velocity. mapping (PVM) is not straightforward because of the absence of a validated clinical flow quantification technique. The aim of this study was to evaluate PVM by investigating its precision, both in vitro and in vivo, in a 1.5 Tesla scanner In the former case, steady and pulsatile flow experiments were conducted using an aortic model under a variety of flow conditions (steady : 0.1-5.5 L/min, pulsatile. 10-75 mL/cycle). In the latter case, PVM measurements were taken in the ascending aorta often subjects, seven of which hem aortic regurgitation. Each velocity measurement was taken twice, with the slice perpendicular to the long axis of the aorta. Comparison between, the measured and true flow rates and volumes confirmed the high accuracy of PVM in measuring pou in vitro (p > 0.85). The in vitro precision of PVM was found to be very high (steady: y = 1.00x + 0.02. r = 0.999: pulsatile: y = 0.98x + 0.72. r = 0.997: x: measurement #1, y : measurement #2) and this was confirmed by Bland-Airman analysis. Of great clinical significance was the high level of the in vivo precision (y = 1.01x - 0.04. r = 0.993), confirmed statistically (p = 1.00). In conclusion. PVM provides repeatable bloodflow measurements. The high in vitro accuracy and precision, combined with the high in vivo precision, are key factors for the establishment of PVM as the gold-standard to quantify bloodflow.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available